Equities Market Summary for January 29th Trading
Equities Market Summary for January 29th TradingS&P 500 OverviewThe S&P 500 declined by 0.5% on Wednesday, Jan. 29, closing at 6,039.3.Other major indices followed suit: the Nasdaq Composite f...
Equities Market Summary for January 29th TradingS&P 500 OverviewThe S&P 500 declined by 0.5% on Wednesday, Jan. 29, closing at 6,039.3.Other major indices followed suit: the Nasdaq Composite f...
Last stage before regulatory reviewLarge trials (30,000 people) to assess safety, efficacyHalf receive vaccine, half receive placeboSuccess: half as many (or fewer) infections for those on vaccineU.S,...
Walgreens Boots Alliance Inc.'s online vaccine-booking system stopped working for several hours on Tuesday, preventing people from making appointments to get a Covid-19 vaccine. Visitors to...
Market Recap: Equities Decline Ahead of Auto Tariff Announcement – March 26thU.S. stock markets closed lower on Wednesday as investors braced for the expected announcement of new auto tariffs, fueli...
March 31st Market SummaryEquities Rebound Amid Tariff ConcernsU.S. stock markets closed mostly higher on Monday as major indexes recovered earlier losses, despite growing concerns over potential new t...
As you all know, the Robinhood clique is a thing and they all seem to tag team on a stock or a few selected stocks as soon as many people start to buy it. For some reason, some stocks are ...
Super Micro Stock Falls Over 8% Amid Nasdaq 100 Delisting ConcernsSuper Micro Computer (SMCI) saw its shares tumble over 8% on Tuesday, as speculation mounted about its potential removal from the...
Last Tuesday, Merck (MRK) revealed its intentions to collaborate with IAVI, a nonprofit scientific organization to develop a potential COVID-19 vaccine. Following the announcement, Merck shares went u...
Goldman Sachs (GS) in a Friday note to investors said they doubted the most dollar-positive outcome when the year finally ends. In its Friday note to investors, Goldman Sachs recommends short-position...
U.S. President Joe Biden on Tuesday announced the historic collaboration between rivals Merck and Johnson & Johnson.Merck will help Johnson & Johnson make its single-shot coronavirus vaccine, ...